Trastuzumab-Induced Myocardiotoxicity Mimicking Acute Coronary Syndrome

Trastuzumab-Induced Myocardiotoxicity Mimicking Acute Coronary Syndrome

Trastuzumab is an important biological agent in the treatment of HER2-positive breast cancer, with effects on response rates, progression-free survival, overall survival and quality of life. Although this drug is well tolerated in terms of adverse effects, trastuzumab-associated myocardiotoxicity ha...

Full description

Bibliographic Details
Main Authors: K.B. Ribeiro, C.H. Miranda, J.M. Andrade, L.G. Galli, D.G. Tiezzi, H.F. Oliveira, F.E. Zola, G. Volpe, A. Pazin-Filho, F.M. Peria
Format: Article
Language:English
Published: Karger Publishers 2012-03-01
Series:Case Reports in Oncology
Subjects:
Breast cancer
Trastuzumab
Myocardiotoxicity
Acute coronary syndrome
Online Access:http://www.karger.com/Article/FullText/337576

Internet

http://www.karger.com/Article/FullText/337576

Similar Items